Interleukin-2 in clinical trials : Other factors to be considered. Authors' replyNANNINI, Esteban C; EMERY, Sean; LANE, H. Clifford et al.The Journal of infectious diseases. 2001, Vol 183, Num 4, pp 679-680, issn 0022-1899Article

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumorsBOSLY, A; GUILLAUME, T; SYMANN, M et al.GUILLAUME, T; Experimental hematology. 1992, Vol 20, Num 8, pp 962-968, issn 0301-472XArticle

Serum interleukin-2 receptor levels measured by enzyme immunoassay in heart and kidney transplanted patientsDE MARIA, R; ZUCCHELLI, G. C; CLERICO, A et al.International journal of tissue reactions. 1989, Vol 11, Num 5, pp 261-265, issn 0250-0868, 5 p.Article

Infection after subcutaneous interleukin-2BUTER, J; DE VRIES, E. G. E; SLEIJFER, D. T et al.Lancet (British edition). 1992, Vol 339, Num 8792, issn 0140-6736, p. 552Article

Ascites induced by interleukin-2 in the treatment of renal cancerTHOMAS, H; VALLIS, K. A; WILLIAMS, G et al.British journal of urology (Print). 1990, Vol 65, Num 3, pp 303-305, issn 0007-1331Article

Minireview serum inhibitors of interleukin-2KUCHARZ, E. J; GOODWIN, J. S.Life sciences (1973). 1988, Vol 42, Num 16, pp 1485-1491, issn 0024-3205Article

Chemical cross-linking of IL-2 to high affinity receptors present on glycerol-loaded T cells and membranes prepared from them yields only IL-2/P55 (Tac) complexesSIEKIERKA, J. J; DEGUDICIBUS, S; WADSWORTH, J et al.Annals of the New York Academy of Sciences. 1988, Vol 546, pp 230-231, issn 0077-8923Conference Paper

Interleukin-2-unresponsive immune defects in good syndrome: Letter to the EditorYANG, Otto O; KELESIDIS, Theodoros.Clinical immunology (Orlando, Fla. Print). 2010, Vol 135, Num 3, pp 496-498, issn 1521-6616, 3 p.Article

Increased production of interleukin-2 and IL-2 receptor in primary IgA nephropathySCHENA, F. P; MASTROLITTI, G; JIRILLO, E et al.Kidney international. 1989, Vol 35, Num 3, pp 875-879, issn 0085-2538Article

Response of human glioblastoma cells to recombinant interleukin-2BENVENISTE, E. N; TOZAWA, H; GASSON, J. C et al.Journal of neuroimmunology. 1988, Vol 17, Num 4, pp 301-314, issn 0165-5728Article

Modulation of interleukin 2 activity by Δ⁹-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or Anti-CD3 antibodyNAKANO, Y; PROSS, S. H; FRIEDMAN, H et al.Proceedings of the Society for Experimental Biology and Medicine. 1992, Vol 201, Num 2, pp 165-168, issn 0037-9727Article

Interleukin-2-induced lung injury is mediated by oxygen free radicalsKLAUSNER, J. M; PATERSON, I. S; GOLDMAN, G et al.Surgery. 1991, Vol 109, Num 2, pp 169-175, issn 0039-6060Article

Blocking of interleukin-2 production, but not the tissue destruction induced by cytotoxic T cells, by cyclosporineNOBLE, R. L; STEINMULLER, D.Transplantation. 1989, Vol 47, Num 2, pp 322-326, issn 0041-1337, 5 p.Conference Paper

Chemotherapy subsequent to recombinant interleukin-2 immunotherapy: protocol for enhanced tumoricidal activityADES, E. W; MCKEMIE, C. R. III; WRIGHT, S et al.Natural immunity and cell growth regulation. 1987, Vol 6, Num 5, pp 260-268, issn 0254-7600Article

Interleukin 2 receptor in rat heart allograft rejectionBOUCHOT, O; ANEGON, I; ROMANIUK, A et al.Transplantation. 1989, Vol 48, Num 6, pp 918-922, issn 0041-1337, 5 p.Article

Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinomaYAMAGUCHI, K; NISHIMURA, Y; TAKATSUKI, K et al.The Journal of laboratory and clinical medicine. 1990, Vol 116, Num 4, pp 457-461, issn 0022-2143Article

Interleukin-2 : further progress through greater understandingPARKINSON, D. R.Journal of the National Cancer Institute. 1990, Vol 82, Num 17, pp 1374-1376, issn 0027-8874Article

Effect of interleukin-2 on peripheral blood mononuclear cells in severely injured patientsPROCHAZKA, M; VYHNANEK, F; JIRA, M et al.Acta chirurgica scandinavica. 1987, Vol 153, Num 7-8, pp 401-404, issn 0001-5482Article

Prostaglandin E₂ (PGE₂)-dependent suppression of interleukin α (I-2) production in patients with major traumaFAIST, E; MEWES, A; BAKER, C. C et al.The Journal of trauma. 1987, Vol 27, Num 8, pp 837-848, issn 0022-5282Conference Paper

Rationale and therapeutic basis for patients receiving recombinant interleukin-2DUDJAK, L. A.Seminars in oncology nursing. 1993, Vol 9, Num 3, pp 3-7, issn 0749-2081, SUP1Article

Résultats globaux et perspectives de l'interleukine-2 dans le traitement des affections malignesHERCEND, T.Pathologie et biologie. 1990, Vol 38, Num 8, issn 0369-8114, p. 782Article

Mitogen plus interleukin 4 induction of C_ε transcripts in B lymphoid cellsROTHMAN, P; LUTZKER, S; COOK, W et al.The Journal of experimental medicine. 1988, Vol 168, Num 6, pp 2385-2389, issn 0022-1007Article

Gene Regulation by 1,25-Dihydroxyvitamin D₃ in CD4 + CD25 + Cells Is Enabled by IL-2GORMAN, Shelley; JUDGE, Melinda A; HART, Prue H et al.Journal of investigative dermatology. 2010, Vol 130, Num 10, pp 2368-2376, issn 0022-202X, 9 p.Article

Interleukin-4-Promoted T Helper 2 Responses Enhance Nippostrongylus brasiliensis-Induced Pulmonary PathologyMEARNS, Helen; HORSNELL, William G. C; HOVING, J. Claire et al.Infection and immunity. 2008, Vol 76, Num 12, pp 5535-5542, issn 0019-9567, 8 p.Article

Label-free, single-molecule detection with optical microcavitiesARMANI, Andrea M; KULKARNI, Rajan P; FRASER, Scott E et al.Science (Washington, D.C.). 2007, Vol 317, Num 5839, pp 783-787, issn 0036-8075, 5 p.Article